Solving the dilemma of proton pump inhibitor nonresponders: targeting the mechanism.

[1]  G. Boeckxstaens,et al.  Baclofen improves symptoms and reduces postprandial flow events in patients with rumination and supragastric belching. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  N. Vakil,et al.  Arbaclofen Placarbil in GERD: A Randomized, Double-Blind, Placebo-Controlled Study , 2011, The American Journal of Gastroenterology.

[3]  G. Boeckxstaens,et al.  A novel reflux inhibitor lesogaberan (AZD3355) as add-on treatment in patients with GORD with persistent reflux symptoms despite proton pump inhibitor therapy: a randomised placebo-controlled trial , 2011, Gut.

[4]  John E Pandolfino,et al.  Esophageal-reflux monitoring. , 2009, Gastrointestinal endoscopy.

[5]  R. Fass.  Proton Pump Inhibitor Failure—What Are the Therapeutic Options? , 2009, The American Journal of Gastroenterology.

[6]  D. Morgan,et al.  The Burden of Gastrointestinal and Liver Diseases, 2006 , 2006, The American Journal of Gastroenterology.

[7]  J. Tack,et al.  Effect of the GABAB agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors , 2003, Gut.

[8]  L. Marzio,et al.  Effect of acute and chronic administration of the GABAB agonist baclofen on 24 hour pH metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease , 2003, Gut.

[9]  D. Castell,et al.  Baclofen decreases acid and non‐acid post‐prandial gastro‐oesophageal reflux measured by combined multichannel intraluminal impedance and pH , 2003, Alimentary pharmacology & therapeutics.

[10]  J. Dent,et al.  Control of transient lower oesophageal sphincter relaxations and reflux by the GABAB agonist baclofen in patients with gastro-oesophageal reflux disease , 2002, Gut.

[11]  L. Marzio,et al.  Effect of acute and chronic administration of the GABA B agonist baclofen on 24 hour pH metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease. , 2003, Gut.

[12]  J. Dent,et al.  Control of transient lower esophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in normal subjects. , 2000, Gastroenterology.